New Haven, CT – NorthEast BioLab, a boutique bioanalytical services contract research organization (CRO), today announced Abhay Pandey as their VP of Business and Corporate Development.
Mr. Pandey will be responsible for crafting and executing the Company’s sales and marketing, capital expenditure, as well as financing strategy. Dr. Vipin Agarwal, President and Chief Executive Officer of NorthEast BioLab, commented, “We are pleased that Mr. Pandey has accepted this role critical to our shared vision of accelerated company growth over the next few years. We are currently undergoing strong operation expansion and will benefit from Mr. Pandey’s experience of identifying and delivering value through distinguished professional services.” “I was very impressed with NorthEast BioLab ’s outstanding customer retention and resourceful operations team” said Mr. Pandey. “I am excited to collaborate and successfully execute our envisioned business strategy, even more, I look forward to meaningfully scaling our sales & marketing unit.”
Mr. Pandey has 10+ years of diverse experience in corporate development, investment banking, and management consulting. Prior to joining NorthEast BioLab, Mr. Pandey served as Sr. Manager Corporate Development at Verizon, where he sourced and executed investment, divestiture, and joint venture opportunities. Prior to Verizon, Abhay served as investment banking associate at Lazard’s middle market advisory group in New York City. At Lazard, Abhay was responsible for advising clients on strategic alternatives including outright company sale or majority equity investment. Previously, Abhay spent several years at ZS Associates as a sales and marketing consultant. ZS Associates is a management consultancy headquartered in Evanston, IL that provides services primarily to pharmaceutical, biotechnology, and healthcare sectors.
Mr. Pandey received a bachelor’s degree in engineering from the Indian Institute of Technology, Kharagpur and a master’s degree in business administration (MBA) from Duke University, Fuqua School of Business. In his free time, he enjoys participating in adventure sports and cooking North Indian and multi-cultural fusion cuisines.
NorthEast BioLab LLC, based in New Haven, CT, is an independent bioanalytical service provider with over 15 years of experience performing small and large molecule bioanalytical services for clinical, preclinical, and drug discovery studies. The company has an excellent track record of advancing PK, BA/BE, TK, Immunogenicity, Biomarker, and custom assays. Services include method development and validation using LC-MS, ELISA, MSD, Luminex, Western Blot, and qPCR, among other technologies. NorthEast BioLab is GLP/GCLP compliant, FDA audited, and DEA and CT State Schedule II-IV approved. Clients span the top ten Pharmaceutical companies and emerging Connecticut and Cambridge, MA biotech. The NorthEast BioLab team has successfully supported numerous preclinical and clinical studies and continues to partner with several leading research and academic institutions across the nation.
For more information about the investment program, please contact:
Abhay Pandey, MBA
VP, Business Development
NorthEast BioLab
925 Sherman Avenue
Hamden, CT 06514
T: (203) 361 3780
E: abhay.pandey@nebiolab.com
